Globe Biotech have received permission from the Directorate General of Drug Administration for manufacturing its vaccine for clinical trial dose.
Asif Mahmud, in-charge of research and development of Globe Biotech, told The Daily Star that they got the permission from DGDA on December 28.
“Now we will submit our human trial protocol plan to the BMRC next week and once we get approval, we will go for clinical trial,” he said.
If everything goes smoothly and as per plan it would not take more than six months to introduce the vaccine in the market.
